Lianyungang, China

Damin Zhao

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Damin Zhao. Retrieved from https://idiyas.com/inventor/damin-zhao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Damin Zhao - Innovator in Pharmaceutical Chemistry

Introduction

Damin Zhao is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development efforts.

Latest Patents

Damin Zhao holds a patent for a pyrazole-substituted cyclopentanol ester derivative. This patent, which is represented by formula (I), pertains to a compound that includes isomers and pharmaceutically acceptable salts. The application highlights the potential uses of this compound in various pharmaceutical applications.

Career Highlights

Damin Zhao is currently associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His work at this esteemed organization has allowed him to focus on developing new pharmaceutical compounds that can lead to advancements in medical treatments.

Collaborations

Damin Zhao has collaborated with several talented individuals in his field, including Yong Gao and Jinan Wang. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Damin Zhao's contributions to pharmaceutical chemistry, particularly through his patent on pyrazole-substituted cyclopentanol ester derivatives, showcase his commitment to advancing medical science. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…